IFP Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-10,050
| Closed | -$479K | – | 4642 |
|
2022
Q4 | $479K | Buy |
10,050
+50
| +0.5% | +$2.38K | 0.01% | 909 |
|
2022
Q3 | $477K | Buy |
+10,000
| New | +$477K | 0.01% | 956 |
|
2021
Q3 | – | Sell |
-350
| Closed | -$2K | – | 4915 |
|
2021
Q2 | $2K | Hold |
350
| – | – | ﹤0.01% | 2784 |
|
2021
Q1 | $2K | Buy |
+350
| New | +$2K | ﹤0.01% | 2711 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 4353 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 4186 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3976 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3861 |
|
2019
Q4 | – | Sell |
-190
| Closed | -$1K | – | 3797 |
|
2019
Q3 | $1K | Buy |
+190
| New | +$1K | ﹤0.01% | 2956 |
|
2019
Q1 | – | Sell |
-250
| Closed | -$4K | – | 3609 |
|
2018
Q4 | $4K | Buy |
+250
| New | +$4K | ﹤0.01% | 2930 |
|
2018
Q2 | – | Sell |
-400
| Closed | -$27K | – | 4082 |
|
2018
Q1 | $27K | Hold |
400
| – | – | ﹤0.01% | 2208 |
|
2017
Q4 | $27K | Sell |
400
-850
| -68% | -$57.4K | ﹤0.01% | 2204 |
|
2017
Q3 | $103K | Sell |
1,250
-155
| -11% | -$12.8K | ﹤0.01% | 1534 |
|
2017
Q2 | $132K | Sell |
1,405
-1,705
| -55% | -$160K | 0.01% | 1372 |
|
2017
Q1 | $198K | Sell |
3,110
-965
| -24% | -$61.4K | 0.01% | 1114 |
|
2016
Q4 | $181K | Sell |
4,075
-4,100
| -50% | -$182K | 0.01% | 1108 |
|
2016
Q3 | $295K | Buy |
8,175
+2,175
| +36% | +$78.5K | 0.02% | 815 |
|
2016
Q2 | $82K | Buy |
+6,000
| New | +$82K | ﹤0.01% | 1456 |
|
2016
Q1 | – | Sell |
-1,250
| Closed | -$44K | – | 3644 |
|
2015
Q4 | $44K | Buy |
+1,250
| New | +$44K | ﹤0.01% | 1687 |
|